Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease | Zendy

Hertzel C. Gerstein | Zendy; Robert E. Ratner | Zendy; Christopher P. Can | Zendy; Patrick W. Serruys | Zendy; Hector Garcia-Garcia | Zendy; GerritAnne van Es | Zendy; Nikheel S. Kolatkar | Zendy; Barbara G. Kravitz | Zendy; Diane Miller | Zendy; Chun Huang | Zendy; Peter J. Fitzgerald | Zendy; Richard W. Nesto | Zendy

Open Access

Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Author(s) -

Hertzel C. Gerstein,

Robert E. Ratner,

Christopher P. Can,

Patrick W. Serruys,

Hector Garcia-Garcia,

GerritAnne van Es,

Nikheel S. Kolatkar,

Barbara G. Kravitz,

Diane Miller,

Chun Huang,

Peter J. Fitzgerald,

Richard W. Nesto

Publication year - 2010

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.109.881003

Subject(s) - medicine , rosiglitazone , cardiology , coronary artery disease , diabetes mellitus , coronary atherosclerosis , type 2 diabetes mellitus , coronary heart disease , disease , endocrinology

Rosiglitazone has several properties that may affect progression of atherosclerosis. The Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in Diabetes Patients With Cardiovascular History (APPROACH) study was undertaken to determine the effect of the thiazolidinedione rosiglitazone on coronary atherosclerosis as assessed by intravascular ultrasound compared with the sulfonylurea glipizide.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research